NIDEK INC Takes on the Medmont E300 Corneal Topographer

June 27, 2017

Medmont International Pty Ltd. and NIDEK Inc. are proud to announce its partnership as of May 25, 2017

NIDEK Inc. will now be offering the Medmont E300 Corneal Topographer to US Ophthalmologists, and Ophthalmic Government tendered competitions.

“This is a great opportunity for both Medmont and NIDEK Inc., as it allows Medmont to have an established and well-respected partner in the Ophthalmology space, but at the same time allows NIDEK Inc. to add a world class topographer to their already great portfolio of instruments”. Robert Heavyside, President of Medmont

“It was an easy decision for NIDEK Inc. to partner with Medmont and to go with the E300 Topographer. We were impressed by the instruments ability to capture from limbus to limbus, plus having a non-invasive and accurate way of detecting dry eye was a big plus too. NIDEK Inc. is happy to be able to offer this instrument to MD’s in the United States”. Motoki Ozawa, President and CEO of NIDEK Inc.

If you are interested in learning more about the E300 Corneal topographer from a NIDEK Inc. representative please contact Senior Product Marketing Manager Keith Effert at keith_effert@nidek.com

About Medmont

Medmont is a global leader in the manufacturing of software and equipment for the ophthalmic market. The company was founded in 1988 and is based in Melbourne, Australia. Medmont’s product range consists of the: E300 Corneal Topographer, M700 Automated Perimeter, DV2000 Diagnostic Imaging Software, and the AT20P Acuity Tester.

You can reach Medmont or one our global distributors at www.medmont.com/contact

About NIDEK

Founded in Gamagori, Japan in 1971, NIDEK continues to be a global leader in research and development, design, manufacture and distribution of ophthalmic equipment. The United States subsidiary based in Silicon Valley, California, provides sales and service for ophthalmic lasers, refractive lasers, and many advanced diagnostic devices.

Contact:

NIDEK Inc.

info@nidek.com

Read more

Nidek Innovation

NIDEK, a global leader in laser and diagnostic instrumentation for the eye care industry, announced today that the United States Food & Drug Administration (FDA) has approved the use of the OPD-Scan III aberrometer and update the Final Fit software to facilitate compatibility with a new aberrometer to perform topography-assisted laser in-situ keratomileusis (LASIK).

Mr. Motoki Ozawa, President of NIDEK stated, “We are pleased to have this approval, and confident the results reflect the quality of our products.”

This demonstrates NIDEK’s commitment to providing an innovative, technologically superior excimer platform for laser vision correction surgery. Furthermore, NIDEK’s NAVEX Quest; EC-5000 Excimer Laser System is a perfect pairing to our strong, world-class product portfolio in unsurpassed diagnostic, surgical instrumentation, optical finishing and dispensing products for vision care.

About NIDEK:
Founded in Gamagori, Japan in 1971, NIDEK continues to be a global leader in research and development, design, manufacture and distribution of ophthalmic equipment. The United States subsidiary based in Silicon Valley, California, provides sales
and service for ophthalmic lasers, refractive lasers, and many advanced diagnostic devices.

For further information contact:
Ron Kaiser
Director of Sales & Marketing
Phone: 800-223-9044– ext. 713
E-mail: ron_kaiser@nidek.com

Read more

News from CEO

We announced today that Nidek is cooperating fully with the Food and Drug Administration (“FDA”) to resolve the issues identified in the FDA’s August 2014 warning letter.

President and CEO, Mr. Motoki Ozawa stated, “our response describing our corrective actions will be filed in a timely manner to the FDA. NIDEK is taking action to address the issues adequately and expeditiously to ensure full compliance with FDA requirements. We expect that our corrective actions will result in full resolution of this matter and we will continue to fulfill our role in providing eye care solutions.”

Read more

Nidek’s AL-Scan Optical Biometer Receives 510K Clearance

[FREMONT, California, July 16, 2014]……NIDEK, a global leader in the design, manufacturing, and distribution of ophthalmic equipment, announces that the United States Food & Drug Administration (FDA) has issued 510K clearance for its revolutionary new AL-Scan Optical Biometer that provides 6 essential values for cataract surgery very quickly. The auto tracking and auto shot capabilities make acquisition speedy and straightforward.

The AL-Scan measures 6 fundamental values for cataract surgery in 10 seconds. These values are, axial length, corneal curvature radius, anterior chamber depth, central corneal thickness, white-to-white distance, and pupil size. The rapid measurement enhances clinical efficiency and patient comfort. The AL-Scan incorporates 3-D auto tracking and auto shot, which provides the operator with the most ease, comfort, and accuracy on all measurements.

Nine IOL calculation formulas including Shammas PL for post-LASIK eyes are incorporated in the AL-Scan. Once measurement is completed, the IOL power is automatically calculated using its own measured data. The AL-Scan can optimize the IOL constants by statistically calculating with the postoperative refractive power. For toric IOL implants, a digital protractor is included to determine the angle between the steepest corneal meridian and the line passing through a landmark such a prominent vessel. The image of the eye with an overlay of the digital protractor can be used in the operating room for accurate alignment of toric IOLs. The AL-Scan represents a fundamental instrument for ophthalmic surgeons.

Mr. Motoki Ozawa, President of Nidek stated. We are pleased to have this clearance, and confident the results reflect the quality of our Diagnostic tools in measurements that assist doctors in pre/post operative evaluations.

About NIDEK Founded in Gamagori, Japan in 1971, NIDEK continues to be a global leader in research and development, design, manufacture and distribution of ophthalmic equipment. The United States subsidiary based in Silicon Valley, California, provides sales and service for ophthalmic lasers, refractive lasers, and many advanced diagnostic devices.

For further information contact:
Ron Kaiser
Director of Sales & Marketing
Phone: 800-223-9044 ext. 713
Email: ron_kaiser@nidek.com

Read more

NIDEK ANNOUNCES ENHANCED ALLIANCE WITH MARCO OPHTHALMIC BY EXPANDING THE SALES DISTRIBUTION CHANNELS OF NEW FUNDUS CAMERA

FOR IMMEDIATE RELEASE

NIDEK ANNOUNCES ENHANCED ALLIANCE WITH MARCO OPHTHALMIC BY EXPANDING THE SALES DISTRIBUTION CHANNELS OF NEW FUNDUS CAMERA

FREMONT, Calif. and JACKSONVILLE, Fla., February 27, 2012 – NIDEK announces a market expansion of the their fundus camera distribution by granting MARCO Ophthalmic exclusive rights to sell NIDEK’s newest fundus camera to the optometry market. NIDEK Inc. will continue to provide sales and service to the Ophthalmology market, as well as service to their existing customers. NIDEK is currently pursuing FDA clearance for its newest fundus camera. Joint distribution of the product will begin once FDA clearance is obtained.

NIDEK is universally recognized as one of the largest manufactures of ophthalmic products with a diverse range of diagnostic and surgical products. MARCO has forged a strong relationship with NIDEK, through outstanding product sales and support, for over three decades. This enhanced collaboration between the two leading companies will fundamentally increase the ability to better serve customers.

“Our customers require more efficiency and diversification in our distribution channels. The best way to meet our increasing customer demand for this product is to focus each of our corporate resources in distinct market segments, to ultimately improve customer satisfaction.” Motoki Ozawa, President and CEO of NIDEK

“We couldn’t be more excited to be adding the NIDEK AFC Non-mydriatic Retinal Camera to our full product line of diagnostic technologies.  The AFC fits perfectly into MARCO’s successful model of increasing efficiency with powerful, easy to use, and high quality instrumentation- that our customers have come to expect.” David Marco, President and CEO of MARCO

About NIDEK:
Founded in Gamagori, Japan in 1971, NIDEK continues to be a global leader in research and development, design, manufacture and distribution of ophthalmic equipment. The United States subsidiary based in Silicon Valley, California, provides sales and service for ophthalmic lasers, refractive lasers, and many advanced diagnostic devices.

About MARCO:
Founded in Jacksonville, FL, in 1967, MARCO continues to expand its position as ‘The Leader in Vision Diagnostics’ with a product line that encompasses classical lane equipment and NIDEK high-tech, automated refractive and retinal instrumentation.  MARCO continues to provide unparalleled training and support to its expanding US customer base.

For More Information Contact:
NIDEK Inc.MARCO Ophthalmic
Frank Wood, MBA Michael J. Crocetta
Marketing Manager Executive Director of Marketing
Phone: 800.223.9044 ext 762 / 800.874.5274 ext 160
frank_wood@nidek.com
mcrocetta@marco.com

Read more

NIDEK Announces FDA Clearance for Multicolor Pattern Scan Laser at American Society of Retina Specialists Meeting in Boston

FOR IMMEDIATE RELEASE

BOSTON, Mass., August 23, 2011 – NIDEK, a global leader in the design, manufacturing, and distribution of ophthalmic equipment, announces their FDA Clearance for the MC-500 Vixi, Multicolor Pattern Scan Laser. This is the first and only pattern scan laser available with a customizable choice of the most popular wavelengths of a 532 nm Green, 577 nm Yellow, or 647 nm Red.

“This pattern scan laser based on our previous successful technology is our most advanced laser yet, finally offering the choice of any configuration of Green, Yellow, or Red colors. This new scanning system demonstrates our continued commitment to the ophthalmic community,” said Motoki Ozawa, President and CEO of NIDEK.

The MC-500 Vixi includes eight preprogrammed scan patterns with a memory function for more effective treatment of various retinal pathologies. Many more scanning patterns are available through the MC-500 Vixi with up to 14 patterns.

With this new laser, NIDEK allows for time saving through fewer sessions, less energy, and more versatility than our conventional models.

This new laser is being introduced at the American Society of Retina Specialists Annual Meeting this weekend in Boston. For more information, visit NIDEK at the ASRS meeting at Booth 300, or call 800.223.9044 ext 762.

About NIDEK

Founded in Gamagori, Japan in 1971, NIDEK continues to be a global leader in the design, manufacture and distribution of ophthalmic equipment. The United States subsidiary based in Silicon Valley, California, provides sales and service for ophthalmic lasers, refractive lasers, and many advanced diagnostic devices.

For More Information Contact:
Frank Wood, MBA, Marketing Manager
800.223.9044 ext 762
frank_wood@nidek.com

Read more

Eyefinity/OfficeMate and NIDEK Announce Equipment Interface For ExamWRITER Version 9.5

FOR IMMEDIATE RELEASE

December 2, 2010


Eyefinity/OfficeMate and NIDEK Announce
Equipment Interface For ExamWRITER Version 9.5

Rancho Cordova, CA, December 2, 2010 – Eyefinity®/OfficeMate®, the leader in electronic medical records, and NIDEK, a global leader in the design, manufacturing and distribution of ophthalmic equipment today announced that they have partnered to provide an equipment interface between ExamWRITER version 9.5 and NIDEK’s NAVIS-EX software. The interface gives eyecare professionals the ability to capture images from NIDEK’s Fundus photography devices and display them in ExamWRITER.

“We are very pleased to offer our ExamWRITER version 9.5 customers this exciting integration with NIDEK and their cutting edge ophthalmic equipment,” said James Kirchner, OD, Eyefinity/OfficeMate Chief Professional Officer. “Giving ExamWRITER users the ability to easily examine their captured retinal images and other patient information is a great benefit to both the eyecare provider and the patients they serve.”

NIDEK’s NAVIS-EX software acquires images from NIDEK’s Fundus photography devices, including the AFC-230/AFC-210 Non-mydriatic Autofocus Fundus Camera and the F-10 Digital Scanning Laser Ophthalmoscope. The interface allows the images to be seamlessly transferred to ExamWRITER version 9.5 and analyzed for the eyecare professional.

“Our newest partnership with Eyefinity/OfficeMate allows NIDEK to better serve our customers by linking our diagnostic products with Eyefinity/OfficeMate’s EHR solutions,” said Motoki Ozawa, President of NIDEK. “The seamless connection between our NAVIS-EX platform and ExamWRITER will greatly increase practice efficiencies.”

###

About Eyefinity®/OfficeMate®

As a VSP GlobalSM company, Eyefinity/OfficeMate is the premier solutions provider serving over 26,000 eyecare professionals with innovative business solutions. Eyefinity/OfficeMate provides Web-based solutions such as frame and lens ordering, claims processing, personalized Web sites with email communication tools, industry webinars and resource guides. Customers throughout the United States and Canada use software solutions including OfficeMate practice management, ReportWRITER patient communications, ExamWRITER electronic medical records and the OfficeMate Enterprise multilocation version.

Eyefinity/OfficeMate has an international presence with its recent acquisition of Monkey Software®, an optical practice management software company headquartered in Melbourne, Australia.  Monkey Software’s industry-leading solution Optomate® serves more than one-third of optometry offices in Australia and New Zealand.

About NIDEK

Founded in Gamagori, Japan in 1971, NIDEK continues to be a global leader in the design, manufacture and distribution of ophthalmic equipment. The United States subsidiary based in Silicon Valley, California, provides sales and service for ophthalmic lasers, refractive lasers, and many advanced diagnostic devices.

Eyefinity/OfficeMate Media Contact:
Jace Duval
Phone: (916) 851.4531
Cell: (916) 842.8396
jacedu@vsp.com

Read more

NIDEK and Compulink Announce Full Integration with NIDEK’s AFC Pro Photographer

FOR IMMEDIATE RELEASE

NIDEK and Compulink Announce Full Integration with NIDEK’s AFC Pro Photographer

FREMONT, Calif. and WESTLAKE VILLAGE, Calif., October 5, 2010 – NIDEK, a global leader in the design, manufacturing, and distribution of ophthalmic equipment, and Compulink, a leader in fully customizable Electronic Health Records (EHR) and Practice Management software, announce their full integration with NIDEK’s AFC Pro Photographer Auto Fundus Camera.

“Our new partnership with Compulink allows NIDEK to better serve the needs of our customers by linking our top selling Auto Fundus Camera with Compulink’s EHR solutions,” said Motoki Ozawa, President of NIDEK.

“The seamless integration of ophthalmic equipment plays a key role in our strategy to provide our clients with the most efficient, easy-to-use and functional EHR solution on the market,” said Link Wilson, President and CEO, Compulink.  “That’s why we’re delighted to have NIDEK as one of our integration partners.”

NIDEK’s AFC Pro Photographer is one of the easiest to use non-mydriatic fundus cameras on the market today. It offers a full frame view with 21 mp of resolution, and comes with auto focus, auto alignment, and auto shot. Combine this with Compulink’s fully customizable and certified Advantage/EHR ™ and this is a complete package for a practice looking to increase efficiencies and deliver better patient care.

About NIDEK

Founded in Gamagori, Japan in 1971, NIDEK continues to be a global leader in the design, manufacture and distribution of ophthalmic equipment. The United States subsidiary based in Silicon Valley, California, provides sales and service for ophthalmic lasers, refractive lasers, and many advanced diagnostic devices.

About Compulink

Compulink is the industry leader in fully customizable Electronic Health Records (EHR) and Practice Management solutions for ophthalmic practices.  Our Eyecare Advantage™ features Advantage/EHR™, certified EHR technology designed specifically for optometrists and backed by Compulink’s EHR Success Guarantee. Used by over 3000 ophthalmic practices and 13 Colleges of Optometry, Advantage also features flexible patient scheduling/tracking, eye care specific exam templates, fully integrated e-Prescribing, patient web registration, electronic claims/eligibility/remittance, Optical POS, and much more.

For More Information:

NIDEK

Frank Wood, MBA

Marketing Manager

800.223.9044 ext. 762

frank_wood@nidek.com

COMPULINK

Rosemary Valenta

Pascale Communications, LLC

917.701.3246

rosemary@pascalecommunications.com

Read more

NIDEK’s Me 1200 Lens Edger Wins 2010 “SILMO d’Or” Award

FOR IMMEDIATE RELEASE

NIDEK’s Me 1200 Lens Edger Wins 2010 “SILMO d’Or” Award

Fremont, Calif., and Hauppauge, New York, October 4, 2010 – NIDEK is proud to announce that its new Multifunction Lens Edger Me 1200 was awarded the prestigious “SILMO d’Or” prize in the category of ‘Optician Workshop’ on September 23rd at the 2010 SILMO Optical Trade Show held in Paris, France.

SILMO is one of the largest and most renowned international optics and eyewear trade shows. Created in 1994, the SILMO d’Or award recognizes products that demonstrate innovation, technology and creativity in various categories. The Me 1200 represents the third consecutive SILMO d’Or award that NIDEK has won, preceded by the OPD-Scan II in 2008 and the ARK-560A in 2009. Distributed exclusively by Santinelli International in the United States, the Me 1200 will make its U.S. debut at the company’s Vision Expo West booth (#4055) on October 7th.

“We are honored to have won this renowned prize for three consecutive years. The prizes strengthen our position as a world leader in the Ophthalmic and Optic industries,” said Motoki Ozawa, President of NIDEK. “These awards confirm that our innovation, functionality, quality and design standards are widely valued. NIDEK strives to contribute to the improvement of worldwide eyecare through its innovative products.”

The Me 1200 integrates a myriad of precision engineered functions which create elaborate lens designs of the highest quality. One of the unit’s key functions is Step Beveling, which processes high-curve lenses for wrap frames. In addition, the Me 1200 features automatic lens periphery calculation for processing the most challenging eyewear. Other functions include Hole Creation, 3D Grooving, Polishing and the ability to process all lens types for all frame styles.

According to Gerard Santinelli, President & CEO of Santinelli International, “The Me 1200 is truly one of the most incredible feats of edging equipment engineering to ever be introduced. This October, we celebrate our 20-year partnership with NIDEK. The Me 1200 exemplifies why our reputation has became synonymous with quality and superior customer satisfaction, and how we’ve become America’s best-selling line of lens edgers.”

For further information contact:

NIDEK                                                 SANTINELLI INTERNATIONAL

Frank Wood, Marketing Manager                   Barbara S. Wagner, Marketing Manager

800.223.9044 ext. 762                                    800.644.3343 ext. 349

frank_wood@nidek.com                                 bwagner@santinelli.com

About NIDEK

Founded in Gamagori, Japan in 1971, NIDEK continues to be a global leader in the design, manufacture and distribution of ophthalmic equipment. The United States subsidiary based in Silicon Valley, California, provides sales and service for ophthalmic lasers, refractive lasers, and many advanced diagnostic devices. NIDEK is committed to delivering accurate and comfortable devices for lens processing for our customers. Lens edging equipment is distributed by Santinelli International, and Vision diagnostic equipment is distributed by Marco Ophthalmic.

About Santinelli International

Over the past 38 years, Santinelli International has grown to become the leading distributor of lens edging equipment in the United States, representing NIDEK systems. Santinelli International has assisted eyecare professionals who are looking to provide better, faster optical service to their patients, while simultaneously increase profits. The family-owned company is the proud recipient of the recent EyeVote Award “Reader’s Choice” for Best Optical Equipment Company and the VCPN Products of the Decade Award.

Read more

NIDEK and First Insight Announce Direct Integration with AFC Pro Photographer Automated Fundus Camera

For Immediate Release:

High resolution photos are available from NIDEK

Contacts:

Donna Lehmann, First Insight Corporation                                 Frank Wood, NIDEK
Marketing Communications Manager                                         Marketing Manager
800.920.1940, ext. 6917 or 503.880.0538 (cell)                      800.223.9044, ext. 762
donnal@first-insight.com frank_wood@nidek.com

NIDEK and MaximEyes by First Insight Announce Direct Integration with AFC Pro Photographer Automated Fundus Camera

Fremont, CA and Hillsboro, OR (September 20, 2010) – NIDEK, a leader in designing and manufacturing equipment for the diagnosis and treatment of retinal diseases, glaucoma, and other vision-impairing afflictions, and First Insight, developer of maximEyes electronic health records and practice management software, launched a direct integration with NIDEK’s AFC Pro Photographer Fundus Camera and maximEyes electronic health records.

“We, at NIDEK, are very excited about our new partnership with First Insight,” said Motoki Ozawa, President of NIDEK. “This allows our customers a comprehensive solution to connect our diagnostic equipment to this innovative electronic health records system.”

“This integration allows doctors to analyze and view captured images and data for the patient using NIDEK’s NAVIS-Ex software”, said Nitin Rai, president of First Insight. “First Insight’s partnership with NIDEK paves the way for future integrations. This integration with the AFC Fundus Camera will ultimately help practices enhance the quality of care they provide to their patients.”

NIDEK’s AFC Pro Photographer is one of the most advanced automated fundus camera available today. Its sophisticated suite of automated tools offers hands-free imaging with the speed and reliability you’ve come to expect. AutoShot captures the retinal image and sends it to a laptop or desktop computer.

About NIDEK

Founded in Gamagori, Japan in 1971, NIDEK continues to be a global leader in the design, manufacture and distribution of ophthalmic equipment. The United States subsidiary based in Silicon Valley, California, provides sales and service for ophthalmic lasers, refractive lasers, and many advanced diagnostic devices. Celebrating over 30 years in the United States, our commitment to customer satisfaction is only exceeded by our dedication to provide the highest level of quality and performance of our equipment.

About First Insight

First Insight® Corporation, based in Hillsboro, Oregon, is widely recognized in the eye care industry as the most versatile and comprehensive practice management and EMR software company. The company’s focus has been to help doctors achieve a paperless practice through its flagship practice management and EHR software maximEyes (www.first-insight.com), optometry.net™ website builder (www.optometry.net) and paradEyes.com® (www.paradEyes.com) online ordering resource. MaximEyes helps thousands of eye care professionals increase revenue, reduce billing errors, improve patient retention, enhance office efficiency, and relieve the stress of impending regulatory standards. For more information about First Insight products and services, call 800.920.1940 or visit www.first-insight.com.

###

Read more

NIDEK Distributors Converge in Japan

Hauppauge, NY – The three U.S. distributors of the optical, ophthalmic and diagnostic products engineered by NIDEK Co. Ltd. recently met with the Japan-based company’s executive management team in Gamagori, Japan to develop strategies for better leveraging their collective brand strength and presenting a more unified front.

NIDEK Inc., Marco Ophthalmic and Santinelli International are the U.S. innovator partner leaders of NIDEK Co. Ltd.’s ophthalmic and surgical products, diagnostic products, and lens edging products, respectively.

For decades, NIDEK Co. Ltd. has earned a strong reputation of innovation, quality and value. Likewise, NIDEK Inc., Marco Ophthalmic and Santinelli International have secured equally strong reputations for personalized product representation, professionalism, technical expertise and strong customer satisfaction. As a result, the three U.S. innovator partners have each long held the highest market share in their individual sectors.

Yet much of the U.S. market may be unaware of the fact that all three represent NIDEK equipment and offer their clients the same level of quality products and customer support. A major goal of these meetings was to determine the best way to communicate this message and explore synergies that will benefit their respective customers.

The trip was also an opportunity for the three companies to pay homage to NIDEK Co. Ltd.’s founder and Chairman, Mr. Hideo Ozawa, who passed away on June 16, 2009.  They reflected on the many memories, contributions and accomplishments of this remarkable man. Simultaneously, the companies bonded together to forge ahead and work with the new NIDEK management team in an effort to continue combined global domination of the industry.

#   #   #

For more information, please contact Barbara S. Wagner at: bwagner@santinelli.com or (800) 644-EDGE, extension 349.

Read more

Founder of NIDEK Leaves OF Legacy of Devices to Improve Eye Care

FOUNDER OF NIDEK LEAVES LEGACY

OF DEVICES TO IMPROVE EYE CARE

June 18, 2009 NIDEK CO., LTD.

Gamagori, JAPAN — Hideo Ozawa, the founder and Chairman of the Board of NIDEK Co., Ltd. passed away June 16, 2009, at a hospital in Gamagori, Japan. He was 79 years old. He left behind a legacy in the ophthalmic and optometric industries that will not be forgotten.
In 1971, Mr. Ozawa led six people to found NIDEK in Gamagori, Japan. His goal was to link optics and electronics. The first Xenon photocoagulator in Japan developed by NIDEK in 1973 became a huge success. In 1982 NIDEK introduced the first auto-refractor. His global vision led to successful subsidiaries in the United States, France, and Italy. Mr. Ozawa received the prestigious “Order of the Rising Sun” award from the Emperor of Japan in 2004.

His ambition was to make things from “invisible to visible.” Today NIDEK operates in about 100 countries worldwide. Mr. Ozawa spent half of his time travelling, meeting with doctors and industry leaders, and developing new technologies in optics, lasers, coating, and diagnostic devices.
His vision and leadership improved the eye and health care of millions of people worldwide.

About NIDEK
NIDEK is a worldwide leader in the medical, optical and coating fields based on leading-edge optoelectronic technology. It develops, manufactures and sells products in the above fields, provide service and export the products internationally. It will continue to support people all over the world for their healthy lives as a leading company in the ophthalmic and optical instrument industries.

For more information contact:

Japan and International:
Mr. Mits Amano, Secretariat Manager, NIDEK Co., Ltd.
+81-533-67-8826 mitsutoshi_amano@nidek.co.jp

United States:
Mr. Frank Wood, Marketing Manager, NIDEK Inc.
800-223-9044 frank_wood@nidek.com

Read more

NIDEK – US Hyperopia Clinical Study Update – 9 Month Update

October 21, 2004 – Fremont, California

NIDEK, Inc. today announced, 9-month clinical data from its US FDA Hyperopia Clinical Study for the treatment of hyperopia and hyperopic astigmatism. This marks an important milestone in the study protocol, as a total of 248 eyes have been treated, with a total number approved in the study at 300 eyes. Over the last 12 months, NIDEK has worked closely with the FDA on the design, data-collection and evaluation of the clinical study. “We are extremely excited and very pleased with these results and the 9-month follow-up data that we are getting from our 7 clinical sites for the new hyperopia software for the US EC-5000 platform. The results we have generated to date all exceed and surpass FDA criteria for hyperopia approval and we look forward to collecting all the 9-month data and thereafter working with the FDA to evaluate our submission process. With the expanded study, we look forward to completing the actual treatments in short order and doing the follow-ups necessary for submission and approval with the FDA”, commented George Waring, III, MD, Medical Monitor for the NIDEK US Hyperopia Study and Chairman of NIDEK’s Medical Advisory Group. Below is the completed data set for all treated eyes in the US clinical trial. A total of 248 eyes have been treated out of 300 approved eyes for the study protocol.

Ted Shimomura, Executive Vice President and General Manager of NIDEK, Inc. stated, “These are excellent and outstanding results and we look forward to expediting collection and review over the coming months and thereafter submitting our data to the FDA for approval in short order. NIDEK is truly dedicated to providing the highest quality solutions and treatment therapies for quality patient care and surgical outcomes in refractive surgery”. “The NIDEK EC-5000 provides expanded treatment options, parameters and an innovative, technologically advanced platform for Refractive Surgery. The NIDEK EC-5000 platform is designed for surgeons’ present use as well as future needs, as the field of Refractive Surgery continues to advance and grow. NIDEK is actively working on developing and launching its own custom ablation and wavefront technology platform with the NIDEK EC-5000 Excimer Laser System. Currently this technology is available internationally and will soon be introduced in the U.S. once clinical studies and regulatory processes are done,” stated Mr. Shimomura. NIDEK plans to begin custom ablation clinical trials in the United States in the next few months, using its proprietary CATz (Customized Aspheric Treatment Zone) software algorithm and advanced laser hardware. The company has been in detailed discussions with the FDA for the initiation of additional studies to evaluate hardware and software for the NIDEK EC-5000 Excimer Laser System. Additionally, NIDEK and the FDA will review and perform analysis of international clinical experiences with new technologies, including CATz, OATz and OPDCAT software algorithms. NIDEK’s EC-5000 Excimer Laser System is currently approved for the reduction and elimination of myopia in the low, moderate and high ranges from -0.75 to -14.00 diopters (D) and moderate myopia with astigmatism ranging in severity from -1.00 to -8.00 D, with a refractive astigmatism from -0.50 to -4.00 D cylinder by manifest refraction, using LASIK (Laser in-situ Keratomileusis) or PRK (Photorefractive Keratectomy).

 

Read more

NIDEK Receives FDA Marketing Clearance For NIDEK MC-300 – Multicolor Laser Photocoagulator

Fremont, California, April 15, 2005

MC-300 NIDEK MC-300 NIDEK Inc. a US leader in advanced ophthalmic laser technologies announced today that it received FDA marketing clearance for commercial release of its new MC-300 Multicolor Laser Photocoagulator System. The new laser will continue to establish NIDEK as a comprehensive laser provider for the fast growing retinal laser market. The MC-300 laser system has been commercially available in international markets and has received outstanding reviews and clinical results from retinal specialists in Asia and Europe. The NIDEK MC-300 is an advanced multi-color (red, yellow and green) diode-pumped solid-state (DPSS) laser system. The new laser delivers three unique laser wavelengths – 659, 561 and 532 nm – ideal for retinal applications, disease treatments and management. The new retinal photocoagulator features advanced software technologies for accurate and precise energy delivery to the retina. In addition, with advanced SOLIC Technology – the new system features digitally controlled instant duty cycles, permitting the laser to be used at rapid speeds and high powers for extended periods of time without failure and energy decay. The MC-300 laser can be mounted for slit-lamp delivery and requires a standard electric outlet, offering retinal surgeons with advanced delivery capabilities and versatility in either an operating room or in-office use. NIDEK will launch the new MC-300 laser at the American Society For Cataract & Refractive Surgery – ASCRS Annual Meeting in Washington, DC, April 16th – 19th, 2005. “The NIDEK MC-300 is an outstanding laser for retinal applications, delivering a suite of advanced technologies to the retinal specialist. With the introduction of the MC-300, NIDEK continues its long-standing commitment to delivering advanced solutions for all specialties of ophthalmology, including retinal applications. Together with the MC-300 and other diagnostics and laser solutions, NIDEK continues to forge ahead and build a solid franchise for delivering products and solutions that deliver on superior technology, product reliability, performance and outstanding clinical results, with a focus in the areas of cornea, cataract, glaucoma and retina.” commented Mr. Hideo Ozawa, President & Founder of NIDEK, at a recent product release event. Mr. Ted Shimomura, Vice-President & General Manager of NIDEK Inc. commented; “The NIDEK MC-300 is an innovative break-through in ophthalmic multi-wavelength laser technology, delivering a solution that retinal specialists have been asking for in the US market for the last few years. Today there is only one other company that delivers a solution that is really not the ideal platform for retinal laser applications; now NIDEK is introducing a solution that is better in clinical results, more reliable, user-friendly and offers newer technology for the retinal specialist. In the months ahead, we look forward to having the MC-300 becoming the de-facto standard for retinal lasers. With new lasers and diagnostic solutions being introduced at this year’s ASCRS Meeting, NIDEK continues to forge ahead and make stronger in-roads into the US ophthalmic laser and diagnostic instrumentation market.”

Read more

NIDEK YC-1800 Ophthalmic YAG Laser System Given Commercial Release In US

Fremont, California, April 15, 2005

NIDEK Inc. a US leader in advanced ophthalmic laser equipment announced today that it has made it’s new and state-of-the-art YC-1800 Ophthalmic YAG Laser System available for sale to the US market. The new laser platform will further advance and fortify NIDEK’s strong leadership position in the ophthalmic laser industry in the US and on a global basis. The NIDEK YC-1800 is an advanced ophthalmic laser platform, combining innovative laser delivery and output technologies, improved operability, fast operation, super adjustable Nd:YAG offset and compact design with versatility for combination laser systems. NIDEK will release and launch the new YC-1800 laser at the American Society For Cataract & Refractive Surgery ASCRS Annual Meeting in Washington, DC, April 16th – 19th, 2005. “The NIDEK YC-1800 is truly an innovative YAG laser system, unlike any currently available on the market on a global basis. The laser combines advanced application features, laser settings parameters and unique design to deliver to the ophthalmic surgeon a solution unlike any other. NIDEK continues to deliver solutions that offer performance, advanced features, reliability and state-of-the-art technology to the ophthalmic surgeon. We continue our long-standing partnership with the ophthalmic surgeon; dedicated to delivering solutions that will advance patient care and improve treatment.” commented Mr. Hideo Ozawa, President & Founder of NIDEK, at a recent product release event. Mr. Ted Shimomura, Vice-President & General Manager of NIDEK Inc. commented; “The NIDEK YC-1800 is an innovative break-through in ophthalmic YAG laser technology, delivering a suite of features that will provide outstanding reliability and service to the user and enable them to provide excellent patient care. With the YC-1800 Laser, NIDEK further advances and fortifies its strong leadership position in the US in the ophthalmic laser market. With the introduction of this laser platform, we bring to the US market our 5th generation Nd:YAG Laser solution – over 20 years of continued innovation and excellence. NIDEK is dedicated to delivering outstanding product reliability with a keen eye on advanced technologies for the ophthalmic industry. We look forward to the YC-1800 becoming the standard of care with every ophthalmic surgeon. The 2005 ASCRS Meeting is an important one for us, as we are also in the process of introducing other ophthalmic laser solutions and furthering our strong leadership position.”

 

Read more

NIDEK – Two Sister Companies Merge to Combine Efforts in U.S. Ophthalmic Industry

Fremont, California, October 21, 2005

NIDEK – Two Sister Companies Merge to Combine Efforts in U.S. Ophthalmic Industry Fremont, California, October 13, 2005 NIDEK Co., Ltd. announced today that its two wholly owned subsidiary companies – NIDEK Technologies America (NTA) and NIDEK Inc. would merge and consolidate business activities in the US market effective April 1st, 2006. NTA with a focus in commercializing advanced ophthalmic diagnostic instrumentation for corneal and retinal applications, will merge with NIDEK’s U.S. sales and marketing organization – NIDEK Inc. This consolidation and merger is being undertaken to further harmonize and harness commercial synergies and solidify NIDEK’s strong and growing business in the U.S. vision care and ophthalmic industry. The company sees this strategic move as a way to further its product marketing and distribution goals and objectives in the United States. “This is an exciting time for NIDEK’s business operations in the US, as we continue our strong focus on harnessing business and product distribution synergies in the US. ” stated Mr. Hideo Ozawa, President & Founder of NIDEK Co., Ltd. “With this merger / operational consolidation we want to focus our efforts on the strong synergies that both NTA and NIDEK Inc. bring to the marketplace. Bringing the two groups together will allow NIDEK to offer one source for its advanced diagnostics and surgical ophthalmic instrumentation to the visioncare professional in the U.S. Additionally, through this consolidation we aim to streamline business operations – sales, marketing, accounting, customer and product service – enabling NIDEK to focus and achieve its short and long-term goals and objectives. Under one business unit, NIDEK Inc. will continue to provide excellent customer service and deliver to the market innovative, technologically advanced products and services, as it has done for close to 25 years,” added Mr. Hideo Ozawa. “Harnessing synergy is our objective here – by bringing together the two commercial business operations, NIDEK as company will be able to focus on leveraging core competencies of each group and continue to develop and market new and innovative advanced ophthalmic diagnostic instrumentation to the US,” stated Phillip Buscemi, OD, Vice President and General Manager of NIDEK Technologies America. “To our existing and new customers, the business change will be seamless and transparent. We will transfer product marketing, sales, service, and customer support to our sister operation at NIDEK Inc. in Fremont, CA. The goal here is to harness commercial, distribution and operational synergies between the two groups and continue our long standing partnership with our users in the United States”, added Mr. Buscemi. “As we see our business and company dealings in the U.S. grow, its important that we bring together akin and analogous business operations together and by doing this, we continue to harness synergies and organizational core competencies to continue to deliver products and technologies to our customers in the United States and around the world. At NIDEK we want to focus on key strategic areas – diagnostic technologies being one of those. By bring NTA and NIDEK Inc. together, we will continue to drive the advancement of technology and enable NIDEK to continue its strong business history in the U.S. and the global ophthalmic and vision care markets. Our end goal here is to continue to deliver products that offer Visionary Performance to our users around the world”, added Mr. Hideo Ozawa. With worldwide operations headquartered in Gamagori, Japan, NIDEK develops, manufactures and sells laser systems and diagnostic equipment for ophthalmology, optometry, general surgery, gynecology and cosmetic dermatological surgery. NIDEK’s ophthalmic and optometric products are specifically designed for diagnosing and treating retinal diseases, glaucoma, refractive therapies, retinopathy of prematurity, and pre- and post-operative cataract surgery therapy. NIDEK’s surgical products are designed to treat patient in the growing applications of cosmetic laser surgery and laser skin resurfacing. NIDEK distributes its products through a network of distribution partners and a direct sales force.

For further information contact:

Mr. Kuntal Joshi
Title: Director of Global Marketing, NIDEK Co. Ltd.
Phone: 510.226.5700 – ext 803
Fax: 510.226.5750
Email: kuntal_joshi@nidek.com

Mr. David MacLellan
Title: Director of Marketing / Sales, NIDEK Technologies America
Phone: 336.851.0225
Fax: 336.851.0917
Email: dmaclellan@nidektech.com

Read more

NIDEK, Inc. Announces a Significant Increase in Ophthalmic Diagnostic Product Offerings through the Merger with NIDEK Technologies America

Fremont, California , April 3, 2006

NIDEK – Effective April 1st, 2006, NIDEK Technologies America (NTA) of Greensboro, NC, has merged with NIDEK Inc. of Fremont, CA. As a global leader in eye care products for ophthalmology and optometry, NIDEK is consolidating its clinical, development, distribution, marketing and sales efforts in the United States to NIDEK’s location in Fremont, CA. This allows NIDEK to expands both it’s customer base, and increase product offerings to new and existing customers. “This is an exciting time for NIDEK’s business operations in the US, as we continue our strong focus on harnessing business and product distribution synergies in the US,” states Mr. Hideo Ozawa, President & Founder of NIDEK Co., Ltd. “With this merger we want to focus our efforts on the strong synergies that both NTA and NIDEK Inc. bring to the marketplace. Bringing the two groups together will allow NIDEK to offer one source for its advanced diagnostics and surgical ophthalmic instrumentation to the vision care professional in the US.” The focus of NTA is to develop advanced ophthalmic diagnostic instruments for corneal and retinal applications. One of the new releases is the Magellan Mapper, the most accurate system that maps any corneal aberration, providing more information to explain the patient’s vision. Currently, it has the highest resolution of any topography system on the market, and is a leading seller.

NIDEK Inc., a larger corporation, is continually growing to develop an array of laser and optical scanning products that lead the way for improved diagnosis and treatments.

CONTACTS:
Mr. Mitsutoshi Amano, Manager of Corporate Planning NIDEK Co., Ltd.
Phone: 81-533-67-6753
Fax: 81-533-67-6610
Email:mitsutoshi_amano@nidek.co.jp
Website: www.nidek.com

Mr. Frank Wood, Marketing Manager NIDEK, Inc.
Phone: 800-223-9044
Fax: 510-226-5750
Email: frank_wood@nidek.com
Website: www.usa.nidek.com

Read more

IN-VIVO DETECTION OF FUNGAL KERATITIS

Fremont, California, May 19, 2006

NIDEK Inc. announces plans to help doctors cope with the nationwide Fusarium fungal keratitis outbreak. As of late April, a total of 73 cases in the United States had been confirmed with fungal keratitis, with another 113 still under investigation, according to FDA. The Centers for Disease Control and Prevention now list 29 states or territories with a confirmed case or one under investigation. The NIDEK Confoscan4 scanning slit confocal microscope is able to image these infections in-vivo. This allows for a diagnosis in minutes, while traditional techniques involving cultures or biopsies can take a week or longer. “The Confoscan is invaluable to us in early diagnosis of fungal keratitis. Identifying the type of infection and being able to initiate the appropriate treatment as soon as possible is vital to keeping these infections from becoming critical,” says Dr. Eduardo C. Alfonso of the Bascom Palmer Eye Institute of the University of Miami, Miami, Florida. NIDEK has set up a referral website (Confocal Sites) to help doctor’s locate Confoscan microscopes in their area. NIDEK will also be working closely with the doctors at Bascom Palmer to establish a reading center to assist physicians who do not routinely see patients with fungal keratitis and perform imaging with in-vivo corneal confocal microscopy.

NIDEK is a global leader in eye care products for ophthalmology and optometry. With diversified clinical research and continual development, an array of laser and optical scanning products are offered that lead the way for improved diagnosis and treatments.

 

Read more

NIDEK Gains FDA Approval for Hyperopia and Hyperopic Astigmatism Module on EC-5000 Excimer Laser

Fremont, California, October 18, 2006

NIDEK, Inc. a global leader in laser and diagnostic instrumentation for the optical and eye care industry, announced today that the U. S. Food & Drug Administration (FDA) has approved its EC-5000 Excimer Laser for the treatment of hyperopia and hyperopic astigmatism for use in LASIK. With this approval, ophthalmic surgeons are able to treat hyperopia and hyperopic astigmatism (+0.50D to +5.00D sphere and up to 2.00D cylinder) in addition to the current approved range for myopia and myopic astigmatism. Hyperopia or farsightedness may be surgically treated by laser vision correction or LASIK. Mr. Motoki Ozawa, Vice President, NIDEK Co., Ltd stated, “This is a historic event for NIDEK and we are especially pleased to have this long-awaited approval. The excellent and outstanding results from 291 eyes demonstrate NIDEK’s commitment to providing an innovative, technologically superior excimer platform for laser vision correction surgery. Furthermore, NIDEK is actively developing its own custom ablation and wavefront technology platform”. “The EC-5000 Excimer Laser System is a perfect pairing to NIDEK’s strong, world-class product portfolio in unsurpassed diagnostic and surgical instrumentation, optical finishing and dispensing products in vision care”, Mr. Ozawa said. The following chart demonstrates six month follow up results of the safety and effectiveness of the EC-5000 Hyperopia clinical results:

Six Month Follow Up Results (291 eyes)
69% within ± 0.5 D
93% within ± 1.0 D
60% 20/20 or better (UCVA)
86% 20/25 or better (UCVA)
99% 20/40 or better (UCVA)

 

Read more

NIDEK Receives FDA clearance for Excimer Laser System Model CXIII

Fremont, California. November 22, 2006

NIDEK Inc. a global leader in laser and diagnostic instrumentation for the optical and eye care industry, announced that it has received marketing clearance from the Food and Drug Administration (FDA), for its advanced refractive laser surgery system the CXIII EC-5000 Excimer Laser System. With this clearance, NIDEK continues to deliver the latest vision correction solutions to ophthalmologists around the world.

“This clearance is a great step forward and NIDEK is excited to be in a position to help doctors ensure good quality of life for their patients.” said Motoki Ozawa, CEO and President of NIDEK Incorporated.

CXIII, which is already CE-marked approved, offers the latest, innovative solutions for Myopia, Myopic Astigmatism, Hyperopia and Hyperopic Astigmatism in the US. CXIII includes a built-in 200 Hz eye tracker and also available is a built-in LCD “heads-up” monitor that displays operation mode, parameter settings, microns of ablation and image of the patient’s eye for tracking as optional.

Read more

NIDEK Announces Auto-Focus, Auto-Alignment Fundus Camera

Fremont, California. April 18, 2007

NIDEK Inc. announces the release of their new auto-focus, auto-alignment non-mydriatic fundus camera. The AFC-210 Pro Photographer takes true 45° images, without any cropping, and very high resolution of 12.8 mega pixel images. This camera delivers superior diagnostic detail, meeting government standards and reading center criteria for diabetic retinopathy screening.

The highly automated design is so simple to use that, someone with limited experience, can take professional quality retina images after just a few minutes of guidance. The AFC-210 Pro Photographer is ideal for busy optometry or ophthalmology offices, where staff turn-over can be a reoccurring challenge. With this camera, anyone can easily take excellent retina images, even externals. .

These high resolution images are optimal for early diagnostic diabetic screening. Diabetes is one of the world’s fastest growing pandemics, increasingly effecting the population. Early diabetic screening can vastly improve diabetic care, and reduce needless vision loss. Development and implementation of standardized diabetic screening will not only give early detection, and but also improve the ability to treat diabetes earlier.

NIDEK is a global leader in eye care products for ophthalmology and optometry. With diversified clinical research and continual development, an array of optical laser and camera products are offered that lead the way for improved diagnosis and treatments.

For more information, please contact:

Frank Wood
Marketing Manager
NIDEK Inc.
Phone: 800-223-9044
Fax: 510-226-5750
email: frank_wood@nidek.com

Read more

NIDEK Gains FDA Clearance for ORION, a New Auto-Retinal Imaging Device

Fremont, California – Apr 29, 2007 (PRN):

NIDEK, Inc. a global leader in laser and diagnostic instrumentation for the optical and eye care industry, announced today that the U. S. Food & Drug Administration (FDA) has approved the first product of the AutoEaseâ„¢ line called ORION, an Auto-Retinal Imaging device for use in screening patients for retinal diseases such as diabetic retinopathy and AMD.

With this approval, ophthalmologists, optometrists and family physicians are able to identify retinal diseases in patients and refer them to a retinal specialist for further diagnosis and treatment. .

With its ease of use as an Auto-Retinal Imaging device, ORION enables patients to screen their retina without the assistance of a technician. The primary method of operation behind ORION includes a voice synthesizer. The voice prompts the patient through the screening process and captures a 7 micron, high resolution image of the patient’s retina, which can be electronically sent to a retinal specialist for further diagnosis. In addition, ORION can screen both retinas of a patient in less than 2 minutes. .

Mr. Motoki Ozawa, Vice President, NIDEK Co., Ltd stated, “ORION is a perfect addition to NIDEK’s strong, world-class product portfolio in unsurpassed diagnostic and surgical instrumentation, optical finishing and dispensing products in vision care”.

About NIDEK NIDEK is a global leader in diagnostic and surgical eye care products for ophthalmology and optometry focused on developing and delivering innovative technologies that enhance the quality of human life. With diversified clinical research and continual innovative development, an array of laser and optical scanning products offered that lead the way for improved diagnosis and treatments. The relentless commitment to customer satisfaction means NIDEK will diligently strive to continually exceed expectations. .

The NIDEK Inc. logo is available at Here
For more information, contact:NIDEK Corporation Lamar Chandler Director, Global Marketing Phone: +1 800 223 9044 – ext. 726
Email: lamar_chandler@nidek.com
Website: http://www.nidek.com/orion.html NIDEK Technologies Aldo Cocchiglia VP & Managing Director Phone: +39 049 862 9200 Email: aldococchiglia@nidektechnologies.it

Read more

ANNOUNCEMENT OF NEW PRESIDENT AND CEO OF NIDEK CO., LTD.

June 24, 2008 NIDEK CO., LTD.

Gamagori, JAPAN, — NIDEK Co., Ltd. announced that Mr. Hideo Ozawa was appointed Chairman of the Board, and Mr. Motoki Ozawa was promoted to President and CEO. This decision was approved at the Board Meeting, after the Annual Shareholders Meeting on June 24, 2008. Under this new management, NIDEK will continue to target further growth in ophthalmic and aesthetic markets as well as optical systems and the coating business.

Mr. Motoki Ozawa, the new President, initially assumed his post as NIDEK, Co. Ltd. as Vice President in 2005, and has since become President and CEO. Mr. Hideo Ozawa, Chairman, is the founder of NIDEK and has devoted himself to corporate management and to the innovation of the ophthalmic industry since the NIDEK foundation began 37 years ago.

NIDEK started from the conviction of former President Mr. Hideo Ozawa, that he would make things “invisible to visible”. We sincerely appreciate your devoted support that made our growth to date possible. We continue to embrace Mr. Ozawa’s conviction. In my opinion, our corporate social responsibility role will be enhanced in this advanced information age and with our aging societies. We plan to make further efforts to grow through clinical contributions to the healthcare industry that will become beneficial to our societies. Your continued support is greatly appreciated.

About NIDEK CO., LTD.

NIDEK has been doing worldwide business in the medical, optical and coating fields based on leading-edge optoelectronic technology. It develops, manufactures and sells products in the above fields, provide after-sales service and export the products to about 100 countries. It will continue to support people all over the world for their healthy lives as a leading company in the ophthalmic and optical instrument industries. For further information, please visit our web site.

http://www.usa.nidek.com
http://www.nidek.com

 

Read more